Targeted News Service logo

-- Preview Email Newsletter
Public Policy Tipoffs Involving Massachusetts Newsletter for 2026-07-04 ( 36 items )  
ACLU of Nevada Responds to Landmark Ruling on Trump Birthright Citizenship Executive Order (10)
LAS VEGAS, Nevada, June 30 -- The American Civil Liberties Union of Nevada issued the following news release: * * * ACLU of Nevada responds to landmark ruling on Trump birthright citizenship executive order The American Civil Liberties Union of Nevada released the following statement following today's U.S. Supreme Court ruling in Trump v. Barbara. Trump v. Barbarais a nationwide class action brought by the American Civil Liberties Union, ACLU of New Hampshire, ACLU of Maine, ACLU of Massachusetts, Legal Defense Fund, Asian Law Caucus, and t more PR

AG Brown leads multistate opposition to Postal Service's attempt to undermine voting rights (10)
OLYMPIA, Washington, July 2 -- Washington state Attorney General Nick Brown issued the following news release: * * * AG Brown leads multistate opposition to Postal Service's attempt to undermine voting rights * Attorney General Nick Brown co-led a multistate coalition of 24 attorneys general in filing a formal comment letter today opposing the Postal Service's attempt to aid the President's efforts to seize control of elections and restrict mail-in voting through a proposed rule, and asking the Postal Service to withdraw the proposed rule.  more PR

Alexion AstraZeneca Rare Disease Urges Food and Drug Administration to Advance AI Use in Rare Disease Clinical Trials (10)
WASHINGTON, July 3 -- Alexion AstraZeneca Rare Disease, Boston, Massachusetts, offered extensive input to the Food and Drug Administration regarding the agency's AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program. The public comment letter emphasized how artificial intelligence could fundamentally improve trial design and execution in rare diseases, addressing unique challenges such as small patient populations, clinical heterogeneity, and limited natural history data. The group highlighted that rare disease patients experien more ST

Altis Labs Advocates for AI-Derived Endpoints in Early-Phase Oncology Trials to Enhance Drug Development Efficiency (10)
WASHINGTON, July 3 -- Altis Labs, a Boston, Massachusetts-based oncology-focused computational imaging company, submitted a public comment letter to the U.S. Food and Drug Administration regarding the AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program. The company offered detailed recommendations to enhance the pilot's design and execution by integrating artificial intelligence-derived efficacy endpoints in early-phase cancer clinical trials, particularly focusing on solid tumors such as non-small cell lung cancer. Altis Labs more ST

Athenahealth Calls for Extended Timeline and Greater Transparency in CMS Prior Authorization Rules (10)
WASHINGTON, July 3 -- Athenahealth, a Watertown, Massachusetts-based healthcare network provider, submitted a public comment letter to the Centers for Medicare & Medicaid Services expressing support for proposed prior authorization interoperability standards across Medicare Advantage, Medicaid managed care, CHIP, and Qualified Health Plans. The letter emphasizes benefits of expanding electronic prior authorization APIs to drug coverage under medical benefits, aiming to streamline administrative processes and improve patient care timeliness. At more ST

Attorney General Bonta Co-Leads Opposition to Proposed USPS Rule Creating Centralized Voter List, Restricting Mail Voting (10)
SACRAMENTO, California, July 2 -- California Attorney General Rob Bonta issued the following news release: * * * Attorney General Bonta Co-Leads Opposition to Proposed USPS Rule Creating Centralized Voter List, Restricting Mail Voting * OAKLAND -California Attorney General Rob Bonta today co-led a coalition of 24 attorneys general in filing a comment letter opposing a United States Postal Service (USPS) proposed rule that would facilitate the president's efforts to exert greater control over elections and restrict mail-in voting. The coalit more PR

Attorney General Bonta Urges Trump Administration to Withdraw Unlawful Contractor Production and Reporting Requirements (10)
SACRAMENTO, California, July 2 -- California Attorney General Rob Bonta issued the following news release: * * * Attorney General Bonta Urges Trump Administration to Withdraw Unlawful Contractor Production and Reporting Requirements * Proposal would impose unclear, confusing, potentially duplicative, and burdensome obligations on federal contractors and subcontractors OAKLAND -California Attorney General Rob Bonta today co-led a multistate coalition in submitting a comment letter urging the Trump Administration to withdraw a proposed info more PR

Attorney General Clark Joins Multistate Opposition to Postal Service's Attempt to Undermine Voting Rights (10)
MONTPELIER, Vermont, July 2 -- Vermont Attorney General Charity Clark posted the following news release: * * * Attorney General Clark Joins Multistate Opposition to Postal Service's Attempt to Undermine Voting Rights * Attorney General Charity Clark joined a coalition of 24 attorneys general in filing a formal comment letter today opposing the Postal Service's attempt to aid the President's efforts to seize control of elections and restrict mail-in voting through a proposed rule and asking the Postal Service to withdraw the proposed rule.  more PR

ATTORNEY GENERAL RAOUL OPPOSES POSTAL SERVICE'S UNLAWFUL ATTEMPT TO UNDERMINE VOTING RIGHTS (10)
CHICAGO, Illinois, July 2 -- Illinois Attorney General Kwame Raoul issued the following news release: * * * ATTORNEY GENERAL RAOUL OPPOSES POSTAL SERVICE'S UNLAWFUL ATTEMPT TO UNDERMINE VOTING RIGHTS * Chicago - Attorney General Kwame Raoul, as part of a coalition of 24 attorneys general, took action to oppose the U.S. Postal Service's attempt to aid the president's efforts to seize control of elections and restrict mail-in voting through a proposed rule. The coalition is calling on the Postal Service to withdraw the proposed rule, which th more PR

Barry Sample Consulting Urges Food and Drug Administration to Finalize Expansion of 510(k) Exemptions for Federal Workplace Drug Testing Devices (10)
WASHINGTON, July 3 -- Barry Sample Consulting, Boston, Massachusetts, has submitted a public comment letter to the Food and Drug Administration advocating for prompt finalization of the agency's proposed expansion to the 510(k) exemption framework. The proposal seeks to remove the long-standing exclusion of clinical toxicology test systems intended for federally regulated workplace drug testing programs from the Employment & Insurance exemption. The comment highlights the regulatory challenges and market uncertainties created by this exclusion  more ST

Blue Cross Blue Shield of Massachusetts Urges Careful Implementation of Centers for Medicare & Medicaid Services Interoperability Standards and Prior Authorization Rule (10)
WASHINGTON, July 3 -- Blue Cross Blue Shield, Massachusetts, Boston, submitted a public comment letter to the Centers for Medicare & Medicaid Services regarding the agency's proposed Interoperability Standards and Prior Authorization for Drugs rule. The health plan acknowledged the need to streamline prior authorization processes but urged the agency to adopt a measured approach that balances administrative burden with cost management.  The commenter expressed support for integrating drugs covered under a medical benefit into the existing Pri more ST

Brotherhood of Maintenance of Way Employees Division Challenges CSX Automated Track Inspection Waiver Implementation (10)
WASHINGTON, July 3 -- The Brotherhood of Maintenance of Way Employees Division of the International Brotherhood of Teamsters has submitted a public comment letter to the Federal Railroad Administration expressing opposition to CSX Transportation's plan to implement operations under the Automated Track Inspection waiver. The federal agency is part of the U.S. Department of Transportation and is tasked with overseeing the safety and regulation of railroad operations nationwide. The Brotherhood represents skilled railroad workers charged with ins more ST

Cyntegrity Advocates for Focused AI Pilot Program to Optimize Early-Phase Clinical Trials (10)
WASHINGTON, July 3 -- Cyntegrity, Boston, Massachusetts, submitted a public comment letter to the U.S. Food and Drug Administration responding to its Request for Information on the AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program. The company, specializing in risk-based quality management platforms with artificial intelligence capabilities, provided recommendations aimed at shaping a practical and impactful pilot study to integrate AI into early-phase clinical trial management. Cyntegrity questioned the proposed pilot's ini more ST

Department of Energy's Proposal for Periodic Regulatory Review Gains Endorsement From Main Street Foundation (10)
WASHINGTON, July 3 -- The Main Street Foundation, Boston, Massachusetts, has expressed its support for the U.S. Department of Energy's initiative to implement a structured system of periodic retrospective review and conditional sunset provisions for federal regulations. This proposal aims to ensure that regulations continue to meet their intended objectives over time, responding to evolving technologies, legal frameworks, and public needs. The Main Street Foundation's Center for Regulatory Analysis and Engagement (CRAE) submitted a comprehensi more ST

Domino Data Lab Urges Focus on AI Decision Quality and Safety in Early-Phase Clinical Trials Pilot Program (10)
WASHINGTON, July 3 -- Domino Data Lab, a Boston, Massachusetts-based company specializing in data science and analytics platforms, has submitted a public comment letter to the U.S. Food and Drug Administration regarding the agency's "AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program." The letter offers detailed recommendations about how artificial intelligence can be integrated into early-phase clinical trials to improve decision-making quality, patient safety, and operational efficiency while maintaining scientific rigor and more ST

Emily's Entourage Proposes Workshop on Genetic Therapy Development for Cystic Fibrosis to Food and Drug Administration (10)
WASHINGTON, July 3 -- Emily's Entourage, a patient advocacy organization in Cambridge, Massachusetts, submitted a public comment letter to the U.S. Food and Drug Administration regarding future programming for the FDA Rare Disease Innovation Hub. The letter focuses on advancing regulatory science and development pathways for genetic therapies targeting the final 10 percent of people with cystic fibrosis who are not served by current mutation-targeted treatments. Emily's Entourage advocates accelerating research and drug development for cystic  more ST

Flexpa Urges Centers for Medicare & Medicaid Services to Enhance Patient Access API Implementation and Compliance (10)
WASHINGTON, July 3 -- Flexpa, a healthcare technology company in Boston, Massachusetts, has submitted a public comment letter to the U.S. Department of Health and Human Services Centers for Medicare & Medicaid Services concerning proposed regulations aimed at improving interoperability standards and prior authorization for drugs under Medicare and Medicaid programs. The letter supports the goals of extending prior authorization requirements to drugs, specifying implementation guide versions, and requiring payers to report API endpoints, while e more ST

For the First Time in History, Pressley Delivers Frederick Douglass's Famous Speech "What to the Slave is the Fourth of July?" on House Floor (10)
WASHINGTON, July 3 -- Rep. Ayanna Pressley, D-Massachusetts, issued the following news: * * * For the First Time in History, Pressley Delivers Frederick Douglass's Famous Speech "What to the Slave is the Fourth of July?" on House Floor * Ahead of 250 th Anniversary, Pressley Paints Striking Picture of America's Past & Present "Douglass's words endure as both a mirror and a mandate, revealing uncomfortable truths while urging us to fight for an America as good as its promise." Video (YouTube) WASHINGTON - For the first time in history, more PR

Goodwin Advises Morgan Stanley as Sole Underwriter in Digital Realty's Secondary Offering of Common Stock by Blackstone (10)
BOSTON, Massachusetts, July 2 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release: * * * Goodwin Advises Morgan Stanley as Sole Underwriter in Digital Realty's Secondary Offering of Common Stock by Blackstone * The Goodwin Real Estate Capital Markets team advised Morgan Stanley, as sole underwriter, in connection with the largest ever equity REIT secondary block trade. The transaction involved an underwritten registered public offering of 12,310,249 shares of Digital Realty's common stock by affiliates of Blac more PR

Haffenreffer Museum Completes NAGPRA Inventory Linking Human Remains to Wampanoag, Narragansett Tribes (10)
WASHINGTON, July 3 (TNSFR) -- Haffenreffer Museum of Anthropology at Brown University, Bristol, Rhode Island, has completed a NAGPRA inventory of human remains and funerary objects, determining cultural affiliation, according to the U.S. Department of the Interior National Park Service notice. The inventory identified human remains representing at least 80 Native American individuals and nine associated funerary objects, including copper beads, wood fragments, shell, faunal remains, lithics, copper and a projectile point. Museum records do not more PR

Harvard Medical School Pediatrics Professor Ha Cautions Against Revised OMB Rules on Federal Research Funding (10)
WASHINGTON, July 3 -- Taekjip Ha, Ph.D., professor of pediatrics at Harvard Medical School, Boston, Massachusetts, voiced concerns to the U.S. Office of Management and Budget regarding proposed changes to federal financial assistance regulations. Ha, a prominent molecular biophysicist and director at Boston Children's Hospital, highlighted the potential negative impacts on his laboratory's research, training programs, and collaborations in a public comment letter. The letter criticizes the shift in Section 200.205 that would reduce the influen more ST

HealthEdge Software Highlights Implementation Challenges in CMS Prior Authorization Proposal (10)
WASHINGTON, July 3 -- HealthEdge Software Inc., a healthcare digital platform company in Boston, Massachusetts, has provided a public comment letter to the U.S. Department of Health and Human Services Centers for Medicare & Medicaid Services regarding the agency's proposed rule. The rule aims to expand electronic prior authorization requirements and interoperability standards for drugs under Medicare and Medicaid programs. HealthEdge's comments focus on the operational, technical, and vendor readiness implications of the proposals outlined in t more ST

HMH Into Reading Earns Recognition From The Reading League for Evidence-Based Literacy Practices (10)
BOSTON, Massachusetts, June 30 -- HMH Education, a company that says it creates K-12 learning solutions, issued the following news release: * * * HMH Into Reading Earns Recognition from The Reading League for Evidence-Based Literacy Practices The Reading League's newest review gives the highest possible scores for the overall delivery and design of HMH Into Reading. - Learning company HMH today welcomed The Reading League's recent review of HMH Into Reading, Version 3 (2025), which gave the program scores of 1--the strongest evidence of a more PR

International Society for AI Standards in Biomedical Development Urges Focus on Governance in Food and Drug Administration AI Clinical Trial Pilot (10)
WASHINGTON, July 3 -- The International Society for AI Standards in Biomedical Development, Boston Massachusetts, submitted a public comment letter to the U.S. Food and Drug Administration supporting the agency's AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program while emphasizing important governance considerations. As a non-commercial initiative dedicated to AI governance in clinical trials and drug development, ISA-BMD highlighted underexplored areas including how AI influences decision-making, the role of override rates as more ST

ITC Opens Patent Investigation Into Proteomics Systems, Laboratory Supplies (10)
WASHINGTON, July 3 (TNSFR) -- The International Trade Commission has instituted a patent infringement investigation involving proteomics systems, laboratory supplies, software and related products following a complaint filed by Seer Inc., Redwood City, California, and the Brigham and Women's Hospital Inc., Boston, Massachusetts. The notice stems from a complaint filed on May 28, 2026, and supplemented on June 12, 2026, under Section 337 of the Tariff Act of 1930. The complainants allege that imports and sales of proteomics-related products inf more PR

LEADER JEFFRIES ON NPR: "DONALD TRUMP IS DESTROYING THE COUNTRY IN REAL TIME" (10)
WASHINGTON, July 3 (Rep.) -- House Democratic Leader Hakeem Jeffries, D-New York, issued the following news release: * * * LEADER JEFFRIES ON NPR: "DONALD TRUMP IS DESTROYING THE COUNTRY IN REAL TIME" * Today, House Democratic Leader Hakeem Jeffries appeared on NPR's Morning Edition, where he made clear that upon the 250th anniversary of our nation's founding, Democrats are focused on lowering the high cost of living, protecting access to healthcare, cleaning up corruption and winning back the House of Representatives to hold Donald Trump a more PR

LEADER JEFFRIES ON NPR: "DONALD TRUMP IS DESTROYING THE COUNTRY IN REAL TIME" (10)
WASHINGTON, July 3 -- Rep. Hakeem Jeffries, D-New York, issued the following news release: * * * LEADER JEFFRIES ON NPR: "DONALD TRUMP IS DESTROYING THE COUNTRY IN REAL TIME" * Today, House Democratic Leader Hakeem Jeffries appeared on NPR's Morning Edition, where he made clear that upon the 250th anniversary of our nation's founding, Democrats are focused on lowering the high cost of living, protecting access to healthcare, cleaning up corruption and winning back the House of Representatives to hold Donald Trump and Republicans accountable more PR

Massachusetts Health Data Consortium Calls for Extended Timelines and Stronger Standards in Centers for Medicare and Medicaid Services Prior Authorization Rule (10)
WASHINGTON, July 3 -- The Massachusetts Health Data Consortium, Cambridge, has submitted a public comment letter to the Centers for Medicare and Medicaid Services addressing the agency's proposed rule on Medicare and Medicaid programs focusing on interoperability standards and prior authorization for drugs across Medicare Advantage, Medicaid Managed Care Plans, CHIP Agencies, and Qualified Health Plans. In its letter, MHDC emphasizes the need for clearer operational guidelines, extended compliance timelines, and industry-aligned standards adopt more ST

National Consumer Law Center Seeks Updates to Income-Driven Repayment Plan Request Form (10)
WASHINGTON, July 3 -- The National Consumer Law Center, Boston, Massachusetts, has submitted a public comment letter to the U.S. Department of Education regarding proposed revisions to the Income-Driven Repayment Plan Request Form. The organization advocates for borrowers of all income levels, especially low-income clients, and draws attention to necessary corrections in the form and associated loan processing systems to align with new repayment regulations going into effect July 1, 2026. The letter emphasizes the need to update definitions an more ST

Philips Highlights Challenges and Opportunities in Prior Authorization for Durable Medical Equipment Under Medicare and Medicaid (10)
WASHINGTON, July 3 -- Philips, a health technology company headquartered in Cambridge, Massachusetts, submitted a public comment letter to the Centers for Medicare & Medicaid Services addressing issues related to prior authorization requirements under the proposed rule CMS-0062-P. The rule pertains to Medicare and Medicaid programs, focusing on interoperability standards and prior authorization for drugs and durable medical equipment, prosthetics, orthotics, and supplies for Medicare Advantage Organizations, Medicaid Managed Care Plans, state a more ST

Picture Health Highlights Trustworthy AI as Key to Optimizing Early-Phase Clinical Trials (10)
WASHINGTON, July 3 -- Picture Health, Cambridge, Massachusetts, provided a public comment letter to the U.S. Food and Drug Administration addressing the agency's Request for Information on the AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program. The company emphasized the importance of trustworthy, interpretable artificial intelligence in enhancing patient stratification and safety monitoring within early-phase oncology trials. Picture Health offered recommendations aimed at designing an impactful pilot program that leverages t more ST

RI Delegation Announces $33M in Federal BUILD Grants for New Providence Transit Center & Mt. Hope Bridge Renovations (10)
WASHINGTON, July 3 -- Sen. Jack Reed, D-Rhode Island, issued the following news release: * * * RI Delegation Announces $33M in Federal BUILD Grants for New Providence Transit Center & Mt. Hope Bridge Renovations * PROVIDENCE, RI - In an effort to upgrade Rhode Island's transportation infrastructure and improve connectivity and mobility, Rhode Island's Congressional delegation today announced $33 million in new federal funding is coming to the Ocean State in the form of Better Utilizing Investments to Leverage Development (BUILD) grants. T more PR

Sanofi Urges Centers for Medicare & Medicaid Services to Enhance Prior Authorization Process for Prescription Drugs With AI Oversight and Patient Protections (10)
WASHINGTON, July 3 -- Sanofi, a biopharmaceutical company in Cambridge, Massachusetts, submitted a public comment letter to the Centers for Medicare & Medicaid Services regarding the agency's proposed rule on interoperability standards and prior authorization for prescription drugs under Medicare Advantage, Medicaid managed care, and Federally Facilitated Exchanges. The company expressed strong support for CMS's efforts to modernize prior authorization processes to enhance patient access and reduce administrative burdens, while emphasizing the  more ST

Telyria Advocates for Protocol-Bound Signal Packets in Food and Drug Administration AI-Enabled Early-Phase Clinical Trials Pilot Program (10)
WASHINGTON, July 3 -- Telyria, Boston, Massachusetts, has submitted a public comment letter to the U.S. Food and Drug Administration regarding the agency's AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program. The letter outlines a comprehensive pilot architecture and evaluation framework designed to enhance early signal visibility, participant safety, and decision quality in early-phase clinical trials, while ensuring data integrity, privacy, and human regulatory oversight remain central. Telyria's response emphasizes structur more ST

Veolia Supports Environmental Protection Agency's Updated PFAS Disposal Guidance With Calls for Clear Standards (10)
WASHINGTON, July 3 -- Veolia, Boston, Massachusetts, submitted a public comment letter to the U.S. Environmental Protection Agency regarding the agency's Interim Guidance on the Destruction and Disposal of Perfluoroalkyl and Polyfluoroalkyl Substances and related materials. Veolia expressed support for EPA's commitment to accelerating action on PFAS pollution through proper destruction and disposal, noting the agency's shift to annual updates of the guidance to keep pace with evolving science and technology. Veolia highlighted its unique capab more ST

Waker Bioscience Calls for Enhancements in FDA Genome Editing Safety Assessment Guidance (10)
WASHINGTON, July 3 -- Waker Bioscience, Cambridge, Massachusetts, submitted a public comment letter to the U.S. Food and Drug Administration expressing support for the agency's April 2026 draft guidance titled "Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing." The company recommends the FDA finalize the draft guidance, noting its timely nature and comprehensive technical approach which extends the scope of the January 2024 guidance on human gene therapy products incorporating human genome edit more ST